NEW YORK (GenomeWeb) – Veracyte reported after the close of the market on Monday that its third quarter revenues rose 34 percent year over year, as its genomic testing volume rose 23 percent during the same period.

For the three months ended Sept. 30, the South San Francisco, California-based company reported Q3 revenues of $23.5 million, up from revenues of $17.5 million a year ago and beating the average analyst estimate of $21.5 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.